Skip to main content

Table 6 ANOVA of the between-days precision of assays using Meropenem and Piperacillin/Tazobactam

From: Comparative in vitrostudy of the antimicrobial activities of different commercial antibiotic products for intravenous administration

Concentration

Experimental F

Theoretical F

Decision

 

Meropenem

Piperacillin

  

C1

0.2747

0.6425

5.99

Accept H0

C2

0.0169

0.2342

5.99

Accept H0

C3

0.6447

0.4756

5.99

Accept H0

C4

0.8572

0.9325

5.99

Accept H0

C5

0.0712

0.123

5.99

Accept H0